Nexus Surgical and Medicare Ltd Reports Positive Financial Trend Amid Market Volatility

Quarterly Financial Performance: A Clear Upswing

The latest quarter has been a period of significant improvement for Nexus Surgical. The company’s financial trend score surged to 9 from 5 over the past three months, signalling a robust positive momentum. This shift is underpinned by several key metrics reaching their highest levels in recent history.

Net sales for the nine-month period have risen to ₹6.15 crores, reflecting a steady increase in business activity. More importantly, the Profit Before Depreciation, Interest, and Taxes (PBDIT) for the quarter reached ₹0.30 crores, marking the highest quarterly figure recorded by the company. This improvement in operating profitability is a critical indicator of operational efficiency and cost management.

Profit Before Tax excluding Other Income (PBT less OI) also peaked at ₹0.30 crores, aligning with the PBDIT gains and signalling that core business operations are driving profitability rather than one-off income sources. The net profit after tax (PAT) for the quarter stood at ₹0.24 crores, the highest quarterly PAT reported by Nexus Surgical to date. Correspondingly, earnings per share (EPS) rose to ₹0.44, underscoring the company’s enhanced earnings capacity.

Stock Price and Market Capitalisation Context

Despite these positive financial developments, Nexus Surgical’s stock price remained unchanged at ₹19.90 on the latest trading day, with a day’s high of ₹22.00 and a low of ₹19.90. The stock’s 52-week price range is ₹13.26 to ₹25.50, indicating considerable volatility typical of micro-cap stocks. The company’s market capitalisation remains classified as micro-cap, reflecting its relatively small size within the NBFC sector.

Investors should note that the stock’s recent price stability contrasts with its volatile returns over shorter periods. For instance, the stock has declined by 13.44% over the past week and 5.15% over the last month, underperforming the Sensex’s respective returns of -0.85% and -3.51%. However, on a year-to-date basis, Nexus Surgical has delivered a robust 13.71% return, outperforming the Sensex’s negative 12.26% return. Over longer horizons, the stock’s performance has been even more striking, with a 5-year return of 531.75% compared to the Sensex’s 45.41%, although the 10-year return has been negative at -60.16%, lagging the Sensex’s strong 180.55% gain.

Financial Trend Shift: From Flat to Positive

The transition in Nexus Surgical’s financial trend from flat to positive is a significant development for investors and analysts alike. This change reflects not only improved quarterly results but also a potential inflection point in the company’s operational trajectory. The improved financial trend score to 9 (from 5) over the last three months highlights growing confidence in the company’s ability to sustain revenue growth and profitability.

Such a shift is particularly meaningful in the NBFC sector, where companies often face pressure from credit costs, regulatory changes, and market sentiment. Nexus Surgical’s ability to deliver its highest quarterly PBDIT and PAT figures suggests effective management of these challenges and a strengthening business model.

Comparative Sector and Market Performance

While Nexus Surgical’s recent financial performance is encouraging, it is essential to contextualise these results within the broader NBFC sector and market environment. The company’s Mojo Score stands at 50.0, with a Mojo Grade upgraded to Hold from Sell as of 1 April 2026. This upgrade reflects the improved fundamentals but also signals caution given the company’s micro-cap status and inherent volatility.

Comparing the stock’s returns with the Sensex reveals a mixed picture. Although the stock has underperformed the benchmark in the short term, its longer-term returns have been exceptional, particularly over five years. This disparity suggests that while short-term volatility remains a concern, the company has demonstrated the capacity for substantial value creation over extended periods.

Outlook and Investor Considerations

Looking ahead, Nexus Surgical’s recent financial improvements provide a foundation for cautious optimism. The company’s ability to sustain revenue growth and margin expansion will be critical in maintaining its upgraded Mojo Grade and attracting investor interest. However, the micro-cap nature of the stock and its historical volatility necessitate a measured approach.

Investors should monitor upcoming quarterly results for confirmation of this positive trend and assess the company’s strategic initiatives to enhance its market position within the NBFC sector. Additionally, the stock’s relative performance against broader indices and sector peers will remain a key barometer of its investment appeal.

In summary, Nexus Surgical and Medicare Ltd has demonstrated a commendable turnaround in its financial trend, marked by record quarterly profitability and improved earnings metrics. While challenges remain, the company’s recent performance signals a potential inflection point that merits attention from investors seeking exposure to the NBFC micro-cap segment.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →